A randomized, placebo-controlled, first in human phase I single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy male volunteers of the immunostimulant 7HP349

7HP349 - 7 Hills Pharma

https://jitc.bmj.com/content/10/Suppl_2/A631

Lionel Lewis 1; William Schary 2; Siddhartha De 2; Peter Vanderslice 2; Ronald Biediger 3; Yared Hailemichael 4; Darren Woodside 3; William Overwijk 5; Frank Lee 6; Upendra Marathi 2

Oct 6, 2022